Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden

We present encouraging observational data on JAKi in GCA in one of the hitherto largest case series with long-term follow-up. Our clinical experiences will complement the results from the awaited RCT.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research